Journal list Promote Sponsor
verified SJR 1,203 · Q1 • database Scopus / SJR & Web of Science indexed
Journal of immunotherapy (Hagerstown, Md. : 1997)
United States · Lippincott Williams and Wilk...
workspace_premium Q1 — Pharmacology lock Subscription

Journal of immunotherapy (Hagerstown, Md. : 1997)

Journal of immunotherapy (Hagerstown, Md. : 1997) is a journal indexed in SJR in Pharmacology and Immunology with an H index of 108. It has an SJR impact factor of 1,203 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,203.

Journal of immunotherapy (Hagerstown, Md. : 1997) focuses its scope in these topics and keywords: cell, cd, monoclonal, cells, tcell, oncogene, golfig, recombinant, regulatory, specific, ...

ISSN: 1524-9557
Publisher: Lippincott Williams and Wilkins
Category: Pharmacology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,203 Q1
H-index 108
Acceptance rate pie_chart
25% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,203

H-index

108

Docs (year)

54

Docs 3y

148

Total refs

1559

Cites 3y

426

Citable 3y

148

Cites/Doc 2y

2.78

Ref/Doc

28.87

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antibody Therapy

View more

Vaccination with Predesignated or Evidence-Based Peptides for Patients with Recurrent Gynecologic Cancers

View more

Combination Human B7.1/NHS76 and B7.1/Fc Fusion Protein Immunotherapy and CD25+ T-Regulatory Cell Depletion Produces Complete Remissioin of Transplanted Solid Tumors

View more

CNTO859, a Humanized Monoclonal Anti-Tissue Factor Antibody, Inhibits Experimental Tumor Growth in a BxPC-3 Human Pancreatic Adenocarcinoma Xenograft Tumor Model

View more

Clonality of Tumor-Infiltrating Lymphocytes in Human Urinary Bladder Carcinoma

View more

Cervical Cancer Cells Induce Apoptosis of Cytotoxic T Lymphocytes

View more

CD4 and CD8 T-Lymphocyte Recognition of Prostate Specific Antigen in Granulomatous Prostatitis

View more

Carbonic Anyhydrase IX (CAIX) Expression Does Not Correlate with the Renal Cell Cancer (RCC) Patient Response to CCI-779

View more

Bispecific Single-Chain Diabody-Mediated Killing of Endoglin-Positive Endothelial Cells by Cytotoxic T Lymphocytes

View more

Basal Levels of Bio-Humoral Markers in Metastatic Renal Cell Carcinoma

View more

Augmentation of Natural Killer Cell Activity in Mice by Bru-Pel

View more

Augmentation of Antitumor Immune Responses by Multiple Intratumoral Inoculations of Replication-Conditional HSV and Interleukin-12

View more
SHOW MORE ARTICLES

ATP and HMGB1 Act as Endogenous Danger Signals in Cancer

View more

A Novel Vaccine Approach to Stimulate Class I Restricted T Cells

View more

Anti-Angiogenic and Anti-Cancer Activity of Monoclonal Antibodies to CCL-2/MCP-1 (Monocyte Chemoattractant Protein-1)

View more

Angiogenesis

View more

An Inhibitor of the F1 Subunit of ATP Synthase (IF1) Modulates the Activity of Angiostatin on the Endothelial Cell Surface

View more

An Acidic Microenvironment Inhibits Antitumoral Non-Major Histocompatibility Complex-Restricted Cytotoxicity: Implications for Cancer Immunotherapy

View more

Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma

View more

Adoptive Transfer of Anti-idiotypic T Cells Cure Mice of Disseminated B Cell Lymphoma

View more

Adoptive Transfer From Interferon-a-Fed Mice Is Associated With Inhibition of Active Experimental Autoimmune Encephalomyelitis by Decreasing Recipient Tumor Necrosis Factor-a Secretion

View more

Adoptive Immunotherapy of Cancer with Polyclonal Hyperexpanded CD4 and CD8 T Cells Derived from Tumor-Draining Lymph Nodes

View more

Adoptive Immunotherapy

View more

Addition of Histamine to IL-2 Treatment Augments T1 Cell-Funktion in Melanoma Patients In Vivo: Results from a Randomized Clinical Trial of IL-2 with or without Histamine (MP 104)

View more

FAQs